Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Heil

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Cardiovascular and Interventional Radiology|February 28, 2024
Effect of Sarcopenia on the Increase in Liver Volume and Function After Portal Vein EmbolizationPieter J W Arntz, Pim B Olthof, Remon Korenblik, et al.
BJS Open|November 28, 2022
Resectability of bilobar liver tumours after simultaneous portal and hepatic vein embolization versus portal vein embolization alone: meta-analysisRemon Korenblik, Jasper F J A van Zon, Bram Olij, et al.
Patient Safety in Surgery|April 12, 2024
Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot studySvenja Sliwinski, Sara Fatima Faqar-Uz-Zaman, Jan Heil, et al.
Annals of Surgical Oncology|August 5, 2025
Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver RegistryJan Heil, Svenja Sliwinski, Jan D'Haese, et al.
Annals of Surgical Oncology|October 6, 2025
ASO Visual Abstract: Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers-Analysis of the StuDoQ Liver RegistryJan Heil, Svenja Sliwinski, Jan D'Haese, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 8, 2019
Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance programCarmela Caballero, Susen Burock, Lucia Carrion-Alvarez, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 16, 2021
Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patientsJan Heil, Franziska Heid, Wolf O Bechstein, et al.
The British Journal of Surgery|April 25, 2024
Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohortRemon Korenblik, Jan Heil, Jens Smits, et al.
The British Journal of Surgery|August 12, 2023
E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomyFlorian Primavesi, Manuel Maglione, Federica Cipriani, et al.
The Lancet Regional Health. Europe|April 21, 2025
Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trialRemon Korenblik, Sinéad James, Jens Smits, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Cardiovascular and Interventional Radiology|February 28, 2024
Effect of Sarcopenia on the Increase in Liver Volume and Function After Portal Vein EmbolizationPieter J W Arntz, Pim B Olthof, Remon Korenblik, et al.
BJS Open|November 28, 2022
Resectability of bilobar liver tumours after simultaneous portal and hepatic vein embolization versus portal vein embolization alone: meta-analysisRemon Korenblik, Jasper F J A van Zon, Bram Olij, et al.
Patient Safety in Surgery|April 12, 2024
Predictive value of a novel digital risk calculator to determine early patient outcomes after major surgery: a proof-of-concept pilot studySvenja Sliwinski, Sara Fatima Faqar-Uz-Zaman, Jan Heil, et al.
Annals of Surgical Oncology|August 5, 2025
Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers: Analysis of the StuDoQ Liver RegistryJan Heil, Svenja Sliwinski, Jan D'Haese, et al.
Annals of Surgical Oncology|October 6, 2025
ASO Visual Abstract: Textbook Outcome After Major Liver Resection for Primary and Secondary Liver Tumors at Specialized German Hepatobiliary Centers-Analysis of the StuDoQ Liver RegistryJan Heil, Svenja Sliwinski, Jan D'Haese, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 8, 2019
Building a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance programCarmela Caballero, Susen Burock, Lucia Carrion-Alvarez, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 16, 2021
Sarcopenia predicts reduced liver growth and reduced resectability in patients undergoing portal vein embolization before liver resection - A DRAGON collaborative analysis of 306 patientsJan Heil, Franziska Heid, Wolf O Bechstein, et al.
The British Journal of Surgery|April 25, 2024
Liver regeneration after portal and hepatic vein embolization improves overall survival compared with portal vein embolization alone: mid-term survival analysis of the multicentre DRAGON 0 cohortRemon Korenblik, Jan Heil, Jens Smits, et al.
The British Journal of Surgery|August 12, 2023
E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomyFlorian Primavesi, Manuel Maglione, Federica Cipriani, et al.
The Lancet Regional Health. Europe|April 21, 2025
Safety and efficacy of combined portal and hepatic vein embolisation in patients with colorectal liver metastases (DRAGON1): a multicentre, single-arm clinical trialRemon Korenblik, Sinéad James, Jens Smits, et al.
Pageof 3